• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

狂犬病病毒中和机制。

Mechanisms of rabies virus neutralization.

作者信息

Flamand A, Raux H, Gaudin Y, Ruigrok R W

机构信息

Laboratoire de Génétique des Virus, CNRS, Gif sur Yvette, France.

出版信息

Virology. 1993 May;194(1):302-13. doi: 10.1006/viro.1993.1261.

DOI:10.1006/viro.1993.1261
PMID:7683158
Abstract

The number of immunoglobulins necessary to neutralize rabies virus (CVS strain) was estimated using IgG and IgM monoclonal antibodies (MAb) specific to the three antigenic sites of the glycoprotein. It was estimated that below 130 IgG or 30 IgM bound per virions, infectivity was totally preserved. Neutralization occurred for an average of 1 or 2 IgG for 3 spikes and 1 IgM for 9 to 10 spikes on the virus surface. Saturation was obtained for 1 to 3 IgG per spike, depending on the antibody, and 1 IgM for 4 to 5 spikes. This result was confirmed by electron microscopy. Neutralization-resisting mutants which continued to fix the selecting MAb in ELISA were also investigated. In two cases, the lack of neutralization was due to the fact that the maximum number of immunoglobulins bound per virion was below the neutralizing dose. In one case, however, the mutant was able to fix the same number of IgG as the parental strain and was not neutralized, even at saturation. The capacity of the antibodies to reduce the attachment of the virus onto BSR cells was also examined. Every intermediate between no inhibition of the attachment and inhibition by a factor of 20 was found; even in this last case, inhibition of attachment was insufficient to explain the extent of neutralization. No correlation was found between the antigenic site recognized by the antibody and the level of inhibition. IgM inhibited attachment more than IgG and one IgG2b antibody did not inhibit attachment at all. The fusion of virions saturated with this antibody with artificial liposomes was totally inhibited, either specifically or because virus-antibody complexes did not attached to the liposomes.

摘要

使用针对糖蛋白三个抗原位点的IgG和IgM单克隆抗体(MAb)估计中和狂犬病病毒(CVS株)所需的免疫球蛋白数量。据估计,每个病毒粒子结合的IgG低于130或IgM低于30时,感染性完全保留。对于病毒表面的3个刺突,平均1或2个IgG以及9至10个刺突1个IgM可发生中和作用。每个刺突根据抗体不同,1至3个IgG可达到饱和,4至5个刺突1个IgM可达到饱和。这一结果通过电子显微镜得到证实。还研究了在ELISA中继续结合选择的MAb的抗中和突变体。在两种情况下,缺乏中和作用是由于每个病毒粒子结合的免疫球蛋白最大数量低于中和剂量。然而,在一种情况下,突变体能够结合与亲本株相同数量的IgG,即使在饱和状态下也未被中和。还检测了抗体减少病毒与BSR细胞附着的能力。发现了从无附着抑制到20倍抑制之间的各种中间情况;即使在最后这种情况下,附着抑制也不足以解释中和程度。未发现抗体识别的抗原位点与抑制水平之间存在相关性。IgM比IgG更能抑制附着,一种IgG2b抗体根本不抑制附着。用该抗体饱和的病毒粒子与人工脂质体的融合被完全抑制,要么是特异性抑制,要么是因为病毒 - 抗体复合物未附着到脂质体上。

相似文献

1
Mechanisms of rabies virus neutralization.狂犬病病毒中和机制。
Virology. 1993 May;194(1):302-13. doi: 10.1006/viro.1993.1261.
2
Monoclonal antibodies which recognize the acidic configuration of the rabies glycoprotein at the surface of the virion can be neutralizing.能够识别病毒粒子表面狂犬病毒糖蛋白酸性构型的单克隆抗体可能具有中和作用。
Virology. 1995 Jul 10;210(2):400-8. doi: 10.1006/viro.1995.1356.
3
G glycoprotein amino acid residues required for human monoclonal antibody RAB1 neutralization are conserved in rabies virus street isolates.G 糖蛋白的氨基酸残基是人类单克隆抗体 RAB1 中和作用所必需的,在狂犬病病毒街毒株中保守。
Antiviral Res. 2011 Aug;91(2):187-94. doi: 10.1016/j.antiviral.2011.06.002. Epub 2011 Jun 13.
4
Common and different antigenic properties of the rabies virus glycoprotein of strains SAD-Vnukovo and Pitman-Moore.SAD-伏努科沃株和皮特曼-摩尔株狂犬病病毒糖蛋白的共同和不同抗原特性
Acta Virol. 1992 Dec;36(6):541-50.
5
Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus.登革2型病毒包膜蛋白结构域III(ED3)上一个包含显性、型特异性中和决定簇的抗原位点的特征分析
Virology. 2007 Sep 30;366(2):349-60. doi: 10.1016/j.virol.2007.05.042. Epub 2007 Aug 23.
6
Further studies on the mechanism of rabies virus neutralization by a viral glycoprotein-specific monoclonal antibody, #1-46-12.关于病毒糖蛋白特异性单克隆抗体#1-46-12对狂犬病病毒中和机制的进一步研究。
Microbiol Immunol. 2005;49(8):721-31. doi: 10.1111/j.1348-0421.2005.tb03663.x.
7
Novel human monoclonal antibody combination effectively neutralizing natural rabies virus variants and individual in vitro escape mutants.新型人源单克隆抗体组合可有效中和天然狂犬病病毒变种及个体体外逃逸突变体。
J Virol. 2005 Jul;79(14):9062-8. doi: 10.1128/JVI.79.14.9062-9068.2005.
8
IgG neutralization of type A influenza viruses and the inhibition of the endosomal fusion stage of the infectious pathway in BHK cells.A型流感病毒的IgG中和作用以及对BHK细胞感染途径中内体融合阶段的抑制
Virology. 1993 Aug;195(2):413-21. doi: 10.1006/viro.1993.1391.
9
Generation and characterization of human monoclonal antibodies to G5, a linear neutralization epitope on glycoprotein of rabies virus, by phage display technology.利用噬菌体展示技术制备针对狂犬病病毒糖蛋白上线性中和表位G5的人源单克隆抗体并进行鉴定
Microbiol Immunol. 2008 Feb;52(2):89-93. doi: 10.1111/j.1348-0421.2008.00016.x.
10
Two influenza A virus-specific Fabs neutralize by inhibiting virus attachment to target cells, while neutralization by their IgGs is complex and occurs simultaneously through fusion inhibition and attachment inhibition.两种甲型流感病毒特异性Fab片段通过抑制病毒与靶细胞的附着来中和病毒,而它们的IgG的中和作用则较为复杂,通过融合抑制和附着抑制同时发生。
Virology. 2000 Dec 20;278(2):423-35. doi: 10.1006/viro.2000.0631.

引用本文的文献

1
Optimizing rabies mRNA vaccine efficacy via RABV-G structural domain screening and heterologous prime-boost immunization.通过狂犬病病毒糖蛋白(RABV-G)结构域筛选和异源初免-加强免疫优化狂犬病信使核糖核酸(mRNA)疫苗效力
NPJ Vaccines. 2025 Mar 2;10(1):43. doi: 10.1038/s41541-025-01098-w.
2
Modelling the mechanisms of antibody mixtures in viral infections: the cases of sequential homologous and heterologous dengue infections.模拟病毒感染中抗体混合物的机制:连续同源和异源登革热感染的案例。
J R Soc Interface. 2024 Oct;21(219):20240182. doi: 10.1098/rsif.2024.0182. Epub 2024 Oct 16.
3
Development of mRNA rabies vaccines.
mRNA 狂犬病疫苗的研发。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2382499. doi: 10.1080/21645515.2024.2382499. Epub 2024 Jul 28.
4
A modified recombinant adenovirus vector containing dual rabies virus G expression cassettes confers robust and long-lasting humoral immunity in mice, cats, and dogs.一种含有双狂犬病病毒 G 表达盒的改良重组腺病毒载体在小鼠、猫和狗中产生强大而持久的体液免疫。
Emerg Microbes Infect. 2024 Dec;13(1):2300461. doi: 10.1080/22221751.2023.2300461. Epub 2024 Jan 22.
5
Comparative Neutralization Activity of Commercial Rabies Immunoglobulin against Diverse Lyssaviruses.市售狂犬病免疫球蛋白对多种狂犬病病毒的中和活性比较
Vaccines (Basel). 2023 Jul 18;11(7):1255. doi: 10.3390/vaccines11071255.
6
Side-by-side Comparative Study of the Immunogenicity of the Intramuscular and Intradermal Rabies Post-exposure Prophylaxis Regimens in a Cohort of Suspected Rabies Virus Exposed Individuals.肌肉注射与皮内注射狂犬病暴露后预防方案的免疫原性并排比较研究:疑似狂犬病病毒暴露个体队列研究。
Clin Infect Dis. 2023 Sep 18;77(6):910-916. doi: 10.1093/cid/ciad304.
7
Development and Evaluation of an Enzyme-Linked Immunosorbent Assay Targeting Rabies-Specific IgM and IgG in Human Sera.开发和评估一种酶联免疫吸附试验,用于检测人血清中的狂犬病特异性 IgM 和 IgG。
Viruses. 2023 Mar 29;15(4):874. doi: 10.3390/v15040874.
8
Antiviral neutralizing antibodies: from in vitro to in vivo activity.抗病毒中和抗体:从体外到体内活性。
Nat Rev Immunol. 2023 Nov;23(11):720-734. doi: 10.1038/s41577-023-00858-w. Epub 2023 Apr 17.
9
Understanding the SARS-CoV-2 Virus Neutralizing Antibody Response: Lessons to Be Learned from HIV and Respiratory Syncytial Virus.了解 SARS-CoV-2 病毒中和抗体反应:从 HIV 和呼吸道合胞病毒中吸取的教训。
Viruses. 2023 Feb 11;15(2):504. doi: 10.3390/v15020504.
10
An mRNA-based rabies vaccine induces strong protective immune responses in mice and dogs.一种基于 mRNA 的狂犬病疫苗可在小鼠和犬中诱导强烈的保护性免疫应答。
Virol J. 2022 Nov 12;19(1):184. doi: 10.1186/s12985-022-01919-7.